ATE312106T1 - Benzosulfone mit calcium antagonisticher wirkung - Google Patents

Benzosulfone mit calcium antagonisticher wirkung

Info

Publication number
ATE312106T1
ATE312106T1 AT00988414T AT00988414T ATE312106T1 AT E312106 T1 ATE312106 T1 AT E312106T1 AT 00988414 T AT00988414 T AT 00988414T AT 00988414 T AT00988414 T AT 00988414T AT E312106 T1 ATE312106 T1 AT E312106T1
Authority
AT
Austria
Prior art keywords
benzosulfones
antagonistic effect
calcium antagonistic
calcium
effect
Prior art date
Application number
AT00988414T
Other languages
English (en)
Inventor
John H Dodd
James L Bullington
Kenneth C Rupert
Daniel A Hall
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of ATE312106T1 publication Critical patent/ATE312106T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT00988414T 2000-01-12 2000-12-28 Benzosulfone mit calcium antagonisticher wirkung ATE312106T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17565000P 2000-01-12 2000-01-12
PCT/US2000/035508 WO2001051493A1 (en) 2000-01-12 2000-12-28 Benzosulfones with calcium antagonist activity

Publications (1)

Publication Number Publication Date
ATE312106T1 true ATE312106T1 (de) 2005-12-15

Family

ID=22641084

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00988414T ATE312106T1 (de) 2000-01-12 2000-12-28 Benzosulfone mit calcium antagonisticher wirkung

Country Status (14)

Country Link
US (1) US6410553B1 (de)
EP (1) EP1246828B1 (de)
JP (1) JP2003519626A (de)
CN (1) CN1301997C (de)
AR (1) AR026834A1 (de)
AT (1) ATE312106T1 (de)
AU (1) AU783470B2 (de)
CA (1) CA2396962A1 (de)
DE (1) DE60024675T2 (de)
DK (1) DK1246828T3 (de)
ES (1) ES2254258T3 (de)
MX (1) MXPA02006842A (de)
MY (1) MY128383A (de)
WO (1) WO2001051493A1 (de)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4483985A (en) 1978-10-31 1984-11-20 Bayer Aktiengesellschaft Production of 1,4-dihydropyridinecarboxylic acids
US4285955A (en) 1978-10-31 1981-08-25 Bayer Aktiengesellschaft 1,4-Dihydropyridinecarboxylic acids
NZ201395A (en) 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
US4845225A (en) 1986-04-09 1989-07-04 Ortho Pharmaceutical Corporation Substituted thiacycloalkeno [3,2-b] pyridines
US4705785A (en) * 1986-04-09 1987-11-10 Ortho Pharmaceutical Corporation Substituted thiacycloalkeno (3,2-b) pyridines and pharmaceutical compositions and method of use
US4879384A (en) 1988-06-15 1989-11-07 Ortho Pharmaceutical Corporation Preparation of thiocycloalkno [3,2-b] pyridines
US5075440A (en) * 1990-05-03 1991-12-24 Ortho Pharmaceutical Corporation Novel pyrido[2,3-f](1,4)thiazepines and pyrido[3,2-b](1,5)benzothiazepines
DE19532320A1 (de) 1995-09-01 1997-03-06 Bayer Ag Verfahren zur Herstellung von optisch aktiven ortho-substituierten 4-Aryl-Dihydropyridinen
KR20020027350A (ko) 1999-06-14 2002-04-13 오르토-맥네일 파마슈티칼, 인코퍼레이티드 디티에피노[6,5-ｂ]피리딘 및 관련된 조성물 및 방법

Also Published As

Publication number Publication date
DE60024675D1 (de) 2006-01-12
AU783470B2 (en) 2005-10-27
CN1451010A (zh) 2003-10-22
MY128383A (en) 2007-01-31
CA2396962A1 (en) 2001-07-19
EP1246828B1 (de) 2005-12-07
EP1246828A1 (de) 2002-10-09
WO2001051493A1 (en) 2001-07-19
AU2462401A (en) 2001-07-24
DK1246828T3 (da) 2006-04-03
JP2003519626A (ja) 2003-06-24
AR026834A1 (es) 2003-02-26
CN1301997C (zh) 2007-02-28
ES2254258T3 (es) 2006-06-16
US6410553B1 (en) 2002-06-25
US20020049326A1 (en) 2002-04-25
MXPA02006842A (es) 2004-04-05
DE60024675T2 (de) 2006-08-24

Similar Documents

Publication Publication Date Title
DE60144474D1 (de) Variabler modenmittler
DE60320033D1 (de) Benzoazolylpiperazinderivate mit vr1-antagonistischer wirkung
DK1226127T3 (da) Substituerede phenylsulfamoylcarboxamider
DK1440077T3 (da) Syntetiske heparinpentasaccharider
ATE307121T1 (de) Substituierte arylpyrazine
DE60113450D1 (de) Antimikrobielle chinolone
DE60116905D1 (de) Beleuchtungsvorrichtungen
AR028393A1 (es) Iminoazidas substituidas
DE60111845D1 (de) Ecteinaschidin derivate mit antikrebs wirkung
DE60132401D1 (de) Tiefpassfilter
DE60125415D1 (de) Formeinsatz
DE60103582D1 (de) Zusammensetzungen mit kontrollierter Freisetzung
ATE408596T1 (de) Pleuromutilinderivate mit antibakterieller wirkung
ATE264843T1 (de) Antibakterielle mutiline
DE50108881D1 (de) Dimmer
DE60328272D1 (de) Diazabicycloalkan-derivate mit nk1-antagonistischer wirkung
AR028302A1 (es) Feniluracilos substituidos
DE60143148D1 (de) En mit honigwaben
DE50112662D1 (de) Substituierte benzoylcyclohexenone
DE60025370D1 (de) 9a-azalide mit antibakterieller wirkung
DE60315984D1 (de) Substituierte benzisoxazolsulfonamide mit breitbändiger hiv-protease hemmender wirkung
ATA4432000A (de) Streugerät
DE60143209D1 (de) Zweiport-demodulationseinrichtung
DE50106006D1 (de) Streugerät
DE60024675D1 (de) Benzosulfone mit calcium antagonisticher wirkung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1246828

Country of ref document: EP

REN Ceased due to non-payment of the annual fee